Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer

HOME | CONTACT | PATIENT LOGIN | CLINIC LOGIN | FAQ

TRIAL ALERTS

TRIALS SEARCH

Site Listing

Please choose the site that is most convenient for you

Study Name: Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer
3 locations found

Dana-Farber Cancer Institute
Location: Boston, Massachusetts 02115
Dana-Farber at Faulkner Hospital
Location: Boston, Massachusetts 02130
Beth Israel Deaconess Medical Center
Location: Boston, Massachusetts 02215

Home | Investigators | CROs / Sponsors | Clinical Trials Notification | Search Clinical Trials | About Clinical Trials | Links | Terms And Conditions | Sitemap | Suggestions / Feedback

© 1998-2013 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.